🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
230.26
-6.19 (-2.62%)
At close: Nov 20, 2026, 4:00 PM EST
230.62
+0.36 (0.16%)
After-hours: Nov 20, 2026, 7:30 PM EST

Jazz Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
205.95-356.15560.12414.83-224.06-329.67
Depreciation & Amortization
718.6696.3660.07638.7629.47552.48
Loss (Gain) From Sale of Assets
----37.7-
Asset Writedown & Restructuring Costs
831.16947.861080.01577.8-
Stock-Based Compensation
295.83291.13248.05226.84222189.01
Provision & Write-off of Bad Debts
32.1119.1127.7611.1114.5419.67
Other Operating Activities
-224.68-261.38-33.36-75.054.63394.97
Change in Accounts Receivable
-110.38-106.28-21.12-51.88-90.14-92.74
Change in Inventory
-115.54-86.04-45.54-13.42-49.64-48.86
Change in Accounts Payable
-20.1539.85-20.079.6-11.2357.02
Change in Unearned Revenue
-----2.09-2.31
Change in Income Taxes
-31.8837.22-14.7425.22-1.69-15.52
Change in Other Net Operating Assets
111.44134.1424.75-173.96164.6954.45
Operating Cash Flow
1,6921,3561,3961,0921,272778.51
Operating Cash Flow Growth
21.60%-2.88%27.83%-14.15%63.39%-13.46%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-70.75-58.75-38.07-23.96-29.05-27.64
Sale of Property, Plant & Equipment
31.3728.17----
Cash Acquisitions
-830.75-858.05----6,235
Divestitures
----53-
Sale (Purchase) of Intangibles
-130.5-151-10-19-469.15-17.89
Investment in Securities
-100.08-470.28-460.13-120.1-1.041,068
Investing Cash Flow
-977.91-1,510-508.2-163.06-446.23-5,212

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--980.77--5,191
Total Debt Issued
1,226-980.77--5,191
Long-Term Debt Repaid
--781-606-31-582.01-1,321
Total Debt Repaid
-1,031-781-606-31-582.01-1,321
Net Debt Issued (Repaid)
194.9-781374.77-31-582.013,871
Issuance of Common Stock
151.36107.8620.6546.4698.02135.26
Repurchase of Common Stock
-344.94-200.24-369.18-320.71-45.5-35.6
Other Financing Activities
-5.2--5.72---
Financing Cash Flow
-3.88-873.3820.52-305.25-529.493,971

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.356.56-1.681.14-6.22-3.21
Net Cash Flow
710.34-1,021906.55624.83290.03-466.32

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,6221,2971,3581,0681,243750.87
Free Cash Flow Growth
21.33%-4.48%27.13%-14.07%65.53%-15.12%
Free Cash Flow Margin
34.37%30.39%33.37%27.86%33.97%24.27%
Free Cash Flow Per Share
24.3221.2720.5714.8219.8712.58
Levered Free Cash Flow
1,6811,3551,4361,0561,125-138.27
Unlevered Free Cash Flow
1,8441,5301,6511,2781,31237.09

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
248.55248.55314.82333.11270.67138.27
Cash Income Tax Paid
121.81121.81114.91177.8894.68271.22
Change in Working Capital
-166.518.9-76.72-204.449.91-47.95
SEC Filings: 10-K · 10-Q